Antibody–Drug Conjugates for Cancer Therapy

Por Parslow, Adam C., Parakh, Sagun, Lee, Fook-Thean, Gan, Hui K., Scott, Andrew M.
Publicado no Biomedicines (2016)

Internalization, Intracellular Trafficking, and Biodistribution of Monoclonal Antibody 806: A Novel Anti-Epidermal Growth Factor Receptor Antibody

Por Perera, Rushika M, Zoncu, Roberto, Johns, Terrance G, Pypaert, Marc, Lee, Fook-Thean, Mellman, Ira, Old, Lloyd J, Toomre, Derek K, Scott, Andrew M
Publicado em 2007

Quantitative intratumoural microdistribution and kinetics of (131)I-huA33 antibody in patients with colorectal carcinoma

Por Ciprotti, Marika, Chong, Geoffrey, Gan, Hui K, Chan, Anthony, Murone, Carmel, MacGregor, Duncan, Lee, Fook-Thean, Johns, Terrance G, Heath, Joan K, Ernst, Matthias, Burgess, Antony W, Scott, Andrew M
Publicado em 2014

Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA

Por Ma, Yuelong, Kowolik, Claudia M., Swiderski, Piotr M., Kortylewski, Marcin, Yu, Hua, Horne, David A., Jove, Richard, Caballero, Otavia L., Simpson, Andrew J.G., Lee, Fook-Thean, Pillay, Vinochani, Scott, Andrew M.
Publicado em 2011

Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers

Por Burvenich, Ingrid J. G., Lee, Fook-Thean, O’Keefe, Graeme J., Makris, Dahna, Cao, Diana, Gong, Sylvia, Rigopoulos, Angela, Allan, Laura C., Brechbiel, Martin W., Liu, Zhanqi, Ramsland, Paul A., Scott, Andrew M.
Publicado no EJNMMI Res (2016)

A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma

Por Davis, Ian D., Liu, Zhanqi, Saunders, Wayne, Lee, Fook-Thean, Spirkoska, Violeta, Hopkins, Wendie, Smyth, Fiona E., Chong, Geoffrey, Papenfuss, Anthony T., Chappell, Bridget, Poon, Aurora, Saunder, Timothy H., Hoffman, Eric W., Old, Lloyd J., Scott, Andrew M.
Publicado em 2007

A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma

Por Davis, Ian D., Wiseman, Gregory A., Lee, Fook-Thean, Gansen, Denise N., Hopkins, Wendie, Papenfuss, Anthony T., Liu, Zhanqi, Moynihan, Timothy J., Croghan, Gary A., Adjei, Alex A., Hoffman, Eric W., Ingle, James N., Old, Lloyd J., Scott, Andrew M.
Publicado em 2007

In Vitro and In Vivo Evaluation of (89)Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 Therapy

Por Burvenich, Ingrid J.G., Lee, Fook-Thean, Guo, Nancy, Gan, Hui K., Rigopoulos, Angela, Parslow, Adam C., O'Keefe, Graeme J., Gong, Sylvia J., Tochon-Danguy, Henri, Rudd, Stacey E., Donnelly, Paul S., Kotsuma, Masakatsu, Ohtsuka, Toshiaki, Senaldi, Giorgio, Scott, Andrew M.
Publicado no Theranostics (2016)

Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer

Por Ciprotti, Marika, Tebbutt, Niall C., Lee, Fook-Thean, Lee, Sze-Ting, Gan, Hui K., McKee, David C., O'Keefe, Graeme J., Gong, Sylvia J., Chong, Geoffrey, Hopkins, Wendie, Chappell, Bridget, Scott, Fiona E., Brechbiel, Martin W., Tse, Archie N., Jansen, Mendel, Matsumura, Manabu, Kotsuma, Masakatsu, Watanabe, Rira, Venhaus, Ralph, Beckman, Robert A., Greenberg, Jonathan, Scott, Andrew M.
Publicado no J Clin Oncol (2015)

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

Por Scott, Andrew M., Lee, Fook-Thean, Tebbutt, Niall, Herbertson, Rebecca, Gill, Sanjeev S., Liu, Zhanqi, Skrinos, Effie, Murone, Carmel, Saunder, Timothy H., Chappell, Bridget, Papenfuss, Anthony T., Poon, Aurora M. T., Hopkins, Wendie, Smyth, Fiona E., MacGregor, Duncan, Cher, Lawrence M., Jungbluth, Achim A., Ritter, Gerd, Brechbiel, Martin W., Murphy, Roger, Burgess, Antony W., Hoffman, Eric W., Johns, Terrance G., Old, Lloyd J.
Publicado em 2007